Medicine for promoting rise of hemameba number after radiotherapy and chemotherapy and preparation method thereof
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- QINGDAO TUMOR HOSPITAL
- Publication Date
- 2014-06-25
- Estimated Expiration
- Not applicable · inactive patent
Abstract
Description
[0001] technical field
[0002] The invention relates to the technical field of pharmacy, in particular to a medicine for increasing the number of white blood cells after radiotherapy and chemotherapy and a preparation method thereof.
[0003] Background technique
[0004] Leukopenia is a group of syndromes caused by various reasons, and the total number of peripheral blood leukocytes is continuously lower than 4.0×10 9 / L is the main diagnostic basis, and it is relatively common in clinical medicine at present. According to its etiology, it can be divided into two types: unknown cause and secondary, and leukopenia secondary to tumor radiotherapy and chemotherapy is particularly common. Chemoradiotherapy is chemical birth therapy, which is a drug-based treatment for diseases caused by pathogenic microorganisms, parasites, and malignant tumors. Chemotherapy is also the initiation of cancer treatment with drugs that kill tumor cells, sometimes called cytotoxic drugs. Radiat...